ASTRO: Fewer Side Effects With IMRT for Prostate Cancer

Intensity modulated radiation therapy tied to fewer side effects than 3-D conformal radiation

MONDAY, Oct. 3 (HealthDay News) -- Treatment of localized prostate cancer using intensity modulated radiation therapy (IMRT) is associated with a considerable reduction in late bowel and rectal side effects and significantly decreased rectal and bladder toxicity compared to three-dimensional conformal radiation therapy (3D-CRT), according to a study presented the annual meeting of the American Society for Radiation Oncology, held from Oct. 2 to 6 in Miami Beach.

Jeff Michalski, M.D., from Washington University Medical Center in St. Louis, and colleagues conducted a dose-escalation trial to investigate the acute and late toxicities associated with high-dose radiation therapy. A cohort of 748 men with localized prostate cancer randomized to treatment in the high-dose arm were allocated to treatment with 3D-CRT or IMRT. Toxicities were classified from grade zero (no toxicity) to four (severe toxicity). Patient characteristics correlating with toxicity were assessed.

The investigators found that IMRT treatment correlated with a significant decrease in acute grade 2+ rectal/bowel and urinary toxicity and a 26 percent reduction in late grade 2+ rectal and bowel side effects. White men had a significantly (15 percent) increased risk of rectal side effects compared to other races, irrespective of radiation treatment.

"This study supports the continued use of IMRT in the management of prostate cancer. It is a safe and very well-tolerated therapy, with fewer complications than 3D-CRT," Michalski said in a statement.

Press Release
More Information

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95

Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95

Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events